Trial Profile
Glucose lowering by continuous tube feeding and Vildagliptin in addition to insulin in hyperglycaemic acute stroke patients.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 03 Aug 2013
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Vildagliptin (Primary)
- Indications Hyperglycaemia
- Focus Adverse reactions; Therapeutic Use
- Acronyms GLUCOVAS
- 03 Aug 2013 Status changed from recruiting to discontinued as reported by European Clinical Trials Database.
- 01 Aug 2011 New trial record